Page last updated: 2024-09-04

resiquimod and glycolipids

resiquimod has been researched along with glycolipids in 1 studies

Compound Research Comparison

Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010)
(resiquimod)
Studies
(glycolipids)
Trials
(glycolipids)
Recent Studies (post-2010) (glycolipids)
4651431819,0621705,050

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christensen, D; Lattmann, E; Pedersen, GK; Perrie, Y; Roces, CB; Wilkinson, A1

Other Studies

1 other study(ies) available for resiquimod and glycolipids

ArticleYear
Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 12-10, Volume: 291

    Topics: Adjuvants, Immunologic; Animals; Female; Glycolipids; Imidazoles; Lipids; Liposomes; Mice, Inbred BALB C; Quaternary Ammonium Compounds; Toll-Like Receptor 7; Vaccines

2018